BioNTech (NASDAQ:BNTX) is on a roll. The company, along with its big partner Pfizer (NYSE:PFE), has reported a plethora of positive news in recent months for their COVID-19 vaccine, BNT162b2. And now BioNTech has more good news to add.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,